vs
ICU MEDICAL INC（ICUI）与SHOE CARNIVAL INC（SCVL）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是SHOE CARNIVAL INC的1.8倍（$540.7M vs $297.2M），SHOE CARNIVAL INC净利率更高（4.9% vs -2.9%，领先7.8%），SHOE CARNIVAL INC同比增速更快（-3.2% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $19.7M），过去两年SHOE CARNIVAL INC的营收复合增速更高（3.0% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Shoe Carnival Inc是一家美国家庭鞋类零售商，目前在美国中西部、南部、东南部地区以及波多黎各共开设了429家门店。该公司由大卫·拉塞尔于1978年创立，截至2025年，其总部位于南卡罗来纳州福特米尔。
ICUI vs SCVL — 直观对比
营收规模更大
ICUI
是对方的1.8倍
$297.2M
营收增速更快
SCVL
高出11.0%
-14.1%
净利率更高
SCVL
高出7.8%
-2.9%
自由现金流更多
ICUI
多$16.2M
$19.7M
两年增速更快
SCVL
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $297.2M |
| 净利润 | $-15.7M | $14.6M |
| 毛利率 | 37.5% | 37.6% |
| 营业利润率 | 1.0% | 6.3% |
| 净利率 | -2.9% | 4.9% |
| 营收同比 | -14.1% | -3.2% |
| 净利润同比 | 34.0% | -23.9% |
| 每股收益（稀释后） | $-0.63 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUISCVL
| Q4 25 | $540.7M | $297.2M | ||
| Q3 25 | $537.0M | $306.4M | ||
| Q2 25 | $548.9M | $277.7M | ||
| Q1 25 | $604.7M | $262.9M | ||
| Q4 24 | $629.8M | $306.9M | ||
| Q3 24 | $589.1M | $332.7M | ||
| Q2 24 | $596.5M | $300.4M | ||
| Q1 24 | $566.7M | $280.2M |
净利润ICUISCVL
| Q4 25 | $-15.7M | $14.6M | ||
| Q3 25 | $-3.4M | $19.2M | ||
| Q2 25 | $35.3M | $9.3M | ||
| Q1 25 | $-15.5M | $14.7M | ||
| Q4 24 | $-23.8M | $19.2M | ||
| Q3 24 | $-33.0M | $22.6M | ||
| Q2 24 | $-21.4M | $17.3M | ||
| Q1 24 | $-39.5M | $15.5M |
毛利率ICUISCVL
| Q4 25 | 37.5% | 37.6% | ||
| Q3 25 | 37.4% | 38.8% | ||
| Q2 25 | 37.9% | 34.5% | ||
| Q1 25 | 34.7% | 34.9% | ||
| Q4 24 | 36.1% | 36.0% | ||
| Q3 24 | 34.8% | 36.1% | ||
| Q2 24 | 34.8% | 35.6% | ||
| Q1 24 | 32.7% | 35.6% |
营业利润率ICUISCVL
| Q4 25 | 1.0% | 6.3% | ||
| Q3 25 | 2.6% | 8.2% | ||
| Q2 25 | 1.9% | 4.3% | ||
| Q1 25 | 2.1% | 5.3% | ||
| Q4 24 | 6.0% | 8.0% | ||
| Q3 24 | 1.4% | 9.0% | ||
| Q2 24 | 1.3% | 7.5% | ||
| Q1 24 | -1.9% | 7.1% |
净利率ICUISCVL
| Q4 25 | -2.9% | 4.9% | ||
| Q3 25 | -0.6% | 6.3% | ||
| Q2 25 | 6.4% | 3.4% | ||
| Q1 25 | -2.6% | 5.6% | ||
| Q4 24 | -3.8% | 6.3% | ||
| Q3 24 | -5.6% | 6.8% | ||
| Q2 24 | -3.6% | 5.8% | ||
| Q1 24 | -7.0% | 5.5% |
每股收益（稀释后）ICUISCVL
| Q4 25 | $-0.63 | $0.53 | ||
| Q3 25 | $-0.14 | $0.70 | ||
| Q2 25 | $1.43 | $0.34 | ||
| Q1 25 | $-0.63 | $0.53 | ||
| Q4 24 | $-0.97 | $0.70 | ||
| Q3 24 | $-1.35 | $0.82 | ||
| Q2 24 | $-0.88 | $0.63 | ||
| Q1 24 | $-1.63 | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $107.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $683.2M |
| 总资产 | $4.1B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUISCVL
| Q4 25 | — | $107.7M | ||
| Q3 25 | — | $91.9M | ||
| Q2 25 | — | $93.0M | ||
| Q1 25 | — | $123.1M | ||
| Q4 24 | $308.6M | $91.1M | ||
| Q3 24 | $312.5M | $84.5M | ||
| Q2 24 | $302.6M | $69.5M | ||
| Q1 24 | $251.4M | $111.2M |
股东权益ICUISCVL
| Q4 25 | $2.1B | $683.2M | ||
| Q3 25 | $2.1B | $670.7M | ||
| Q2 25 | $2.1B | $653.6M | ||
| Q1 25 | $2.0B | $649.0M | ||
| Q4 24 | $2.0B | $635.7M | ||
| Q3 24 | $2.0B | $618.5M | ||
| Q2 24 | $2.0B | $597.8M | ||
| Q1 24 | $2.1B | $583.4M |
总资产ICUISCVL
| Q4 25 | $4.1B | $1.2B | ||
| Q3 25 | $4.1B | $1.2B | ||
| Q2 25 | $4.1B | $1.1B | ||
| Q1 25 | $4.2B | $1.1B | ||
| Q4 24 | $4.2B | $1.1B | ||
| Q3 24 | $4.3B | $1.1B | ||
| Q2 24 | $4.3B | $1.1B | ||
| Q1 24 | $4.3B | $1.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $33.6M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $19.7M |
| 自由现金流率自由现金流/营收 | 6.6% | 6.6% |
| 资本支出强度资本支出/营收 | 4.6% | 4.7% |
| 现金转化率经营现金流/净利润 | — | 2.30× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $35.1M |
8季度趋势，按日历期对齐
经营现金流ICUISCVL
| Q4 25 | $60.6M | $33.6M | ||
| Q3 25 | $56.7M | $13.3M | ||
| Q2 25 | $11.2M | $-9.6M | ||
| Q1 25 | $51.3M | $44.5M | ||
| Q4 24 | $40.2M | $17.3M | ||
| Q3 24 | $36.1M | $23.7M | ||
| Q2 24 | $82.0M | $17.1M | ||
| Q1 24 | $45.8M | $53.4M |
自由现金流ICUISCVL
| Q4 25 | $36.0M | $19.7M | ||
| Q3 25 | $27.6M | $2.2M | ||
| Q2 25 | $-8.5M | $-23.0M | ||
| Q1 25 | $36.7M | $36.2M | ||
| Q4 24 | $16.1M | $8.3M | ||
| Q3 24 | $16.2M | $18.2M | ||
| Q2 24 | $62.5M | $6.9M | ||
| Q1 24 | $29.9M | $40.7M |
自由现金流率ICUISCVL
| Q4 25 | 6.6% | 6.6% | ||
| Q3 25 | 5.1% | 0.7% | ||
| Q2 25 | -1.5% | -8.3% | ||
| Q1 25 | 6.1% | 13.8% | ||
| Q4 24 | 2.6% | 2.7% | ||
| Q3 24 | 2.7% | 5.5% | ||
| Q2 24 | 10.5% | 2.3% | ||
| Q1 24 | 5.3% | 14.5% |
资本支出强度ICUISCVL
| Q4 25 | 4.6% | 4.7% | ||
| Q3 25 | 5.4% | 3.6% | ||
| Q2 25 | 3.6% | 4.8% | ||
| Q1 25 | 2.4% | 3.2% | ||
| Q4 24 | 3.8% | 3.0% | ||
| Q3 24 | 3.4% | 1.7% | ||
| Q2 24 | 3.3% | 3.4% | ||
| Q1 24 | 2.8% | 4.5% |
现金转化率ICUISCVL
| Q4 25 | — | 2.30× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | 0.32× | -1.03× | ||
| Q1 25 | — | 3.04× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | 1.05× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | — | 3.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
SCVL
暂无分部数据
